Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 22% ± 8% |
Insufficient scRNA-seq data for expression of VANGL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 1259.71 | 170 / 170 | 100% | 19.12 | 457 / 459 |
breast | 100% | 806.43 | 457 / 459 | 100% | 22.83 | 1116 / 1118 |
bladder | 100% | 1479.81 | 21 / 21 | 99% | 16.32 | 500 / 504 |
intestine | 100% | 1429.98 | 965 / 966 | 99% | 14.86 | 523 / 527 |
esophagus | 100% | 1581.38 | 1444 / 1445 | 99% | 28.90 | 181 / 183 |
prostate | 100% | 982.87 | 245 / 245 | 99% | 12.43 | 495 / 502 |
stomach | 100% | 975.33 | 358 / 359 | 99% | 15.48 | 282 / 286 |
skin | 100% | 2028.55 | 1809 / 1809 | 97% | 16.83 | 460 / 472 |
ovary | 97% | 718.73 | 175 / 180 | 100% | 27.08 | 430 / 430 |
pancreas | 99% | 722.85 | 324 / 328 | 96% | 13.14 | 170 / 178 |
thymus | 100% | 1343.29 | 653 / 653 | 93% | 8.98 | 565 / 605 |
kidney | 99% | 774.07 | 88 / 89 | 92% | 11.47 | 832 / 901 |
lung | 92% | 757.37 | 529 / 578 | 99% | 14.50 | 1146 / 1155 |
adrenal gland | 100% | 1368.09 | 258 / 258 | 55% | 3.08 | 127 / 230 |
liver | 96% | 418.37 | 216 / 226 | 49% | 3.59 | 197 / 406 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.22 | 1 / 1 |
blood vessel | 100% | 1053.36 | 1331 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 904.78 | 1200 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 494.17 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 95% | 595.14 | 821 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 8.24 | 75 / 80 |
brain | 36% | 107.12 | 953 / 2642 | 55% | 3.55 | 390 / 705 |
lymph node | 0% | 0 | 0 / 0 | 38% | 2.10 | 11 / 29 |
peripheral blood | 24% | 177.76 | 219 / 929 | 0% | 0 | 0 / 0 |
muscle | 22% | 59.80 | 176 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
GO_0043473 | Biological process | pigmentation |
GO_0005886 | Cellular component | plasma membrane |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | VANGL1 |
Protein name | Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1) HCG1747659 (VANGL1 protein) (cDNA, FLJ92368) |
Synonyms | hCG_1747659 STB2 |
Description | |
Accessions | Q8TAA9 Q96J52 ENST00000355485.7 [Q8TAA9-1] ENST00000369510.8 [Q8TAA9-2] ENST00000369509.1 [Q8TAA9-1] ENST00000310260.7 [Q8TAA9-1] |